Vincenzo Terlizzi
Founder at Carnis Bioreactors- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Drug Discovery
CourseraMar, 2022- Oct, 2024 -
Python for Data Science, AI & Development
CourseraJan, 2022- Oct, 2024 -
Tools for Data Science
CourseraDec, 2021- Oct, 2024 -
What is Data Science?
CourseraDec, 2021- Oct, 2024
Experience
-
Carnis Bioreactors
-
Netherlands
-
Biotechnology
-
1 - 100 Employee
-
Founder
-
Aug 2019 - Present
-
-
-
UMCG
-
Netherlands
-
Hospitals and Health Care
-
700 & Above Employee
-
PHD Researcher
-
Jul 2013 - Jun 2019
-
-
-
-
PHD Student
-
Jul 2013 - Jun 2016
Pericyte loss is the earliest morphological sign of diabetic retinopathy. We hypothesize that diabetic retinopathy can be delayed or prevented through restoration of pericytes and pericyte function by adipose tissue-derived stem/stromal cells (ADSC). According to surface and internal marker validation, ADSCs share pericyte characteristics, and may have a therapeutic benefit in injured microvessels in the eye. The main aims of this project are to 1) dissect the molecular mechanisms of ADSC-driven pericyte restoration, 2) to investigate the impact of diabetes i.e. long-term hyperglycemia, on the molecular phenotype and function of ADSC and 3) whether ADSC support long-term normalization of the vasculature in the diabetic retina Show less
-
-
Education
-
2009 - 2012
Università degli Studi di Parma
Master of Science - MS, Cell/Cellular and Molecular Biology -
2006 - 2009
Università degli Studi di Modena e Reggio Emilia
Bachelor of Science - BS, Biology/Biological Sciences -
2000 - 2005
Istituto Fermo Corni
High School Diploma, Thermotecnic, fluidodynamic, thermo systems engineering
Community
